Keytruda Shows Remarkable Improvement in Overall Survival for Renal Cancer Patients in Phase 3 Trial
On January 29, 2024, the Phase 3 KEYNOTE-564 trial conducted by Merck investigated the effectiveness of Keytruda as an adjuvant...
On January 29, 2024, the Phase 3 KEYNOTE-564 trial conducted by Merck investigated the effectiveness of Keytruda as an adjuvant...
On January 29, 2024, MoffettNathanson analyst Robert Fishman shared his analysis on TKO Group Holdings (NYSE: TKO), initiating coverage with...
On January 29, 2024, William Blair analyst Louie DiPalma made an exciting announcement, initiating coverage on AAR (NYSE:AIR) with an...
On January 29, 2024, George Gianarikas, an esteemed analyst at Canaccord Genuity, has taken the initiative to cover NuScale Power...
On January 29, 2024, Cingulate Inc. proudly announced the appointment of Jennifer Callahan as their new Chief Financial Officer (CFO),...
ProSomnus, a leading provider of non-CPAP therapy for Obstructive Sleep Apnea (OSA), is stepping up to support patients in the...
On January 29, 2024, Fresh Vine Wine, Inc. made a significant move by finalizing the acquisition of Notes Live, Inc....
On January 29, 2024, Overseas Shipholding Group (OSG) announced that Saltchuk Resources, Inc. had expressed an unsolicited interest in acquiring...
Worksport is excited to announce its plans for expanding its business-to-business (B2B) dealer network in both the United States and...
On January 29, 2024, Ben Mohr, an analyst from Deutsche Bank, made a significant move by initiating coverage on TFI...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com